Samtidig administration af rosiglitazon og gemfibrozil (en hæmmer af CYP2C8) resulterede i en tofoldig stigning i plasmakoncentrationen af rosiglitazon.
Co-administration of rosiglitazone with gemfibrozil (an inhibitor of CYP2C8) resulted in a twofold increase in rosiglitazone plasma concentrations.